Home
TMC vs SVRA Comparison

TMC vs SVRA Comparison

Compare TMC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMC

SVRA

Machine Learning Prediction

ML Decision
TMC
SVRA

Stock Information

Founded
TMC 2011
SVRA 2007

Country
TMC Canada
SVRA United States

Employees
TMC N/A
SVRA N/A

Industry
TMC Metal Mining
SVRA Biotechnology: Pharmaceutical Preparations

Sector
TMC Basic Materials
SVRA Health Care

Exchange
TMC Nasdaq
SVRA Nasdaq

Market Cap
TMC N/A
SVRA 505.8M

IPO Year
TMC N/A
SVRA N/A

Fundamental

Price
TMC $3.04
SVRA $3.22

Analyst Decision
TMC Buy
SVRA Buy

Analyst Count
TMC 2
SVRA 6

Target Price
TMC $3.88
SVRA $8.83

AVG Volume (30 Days)
TMC 14.4M
SVRA 616.7K

Earning Date
TMC 05-16-2025
SVRA 05-16-2025

Dividend Yield
TMC N/A
SVRA N/A

EPS Growth
TMC N/A
SVRA N/A

EPS
TMC N/A
SVRA N/A

Revenue
TMC N/A
SVRA N/A

Revenue This Year
TMC N/A
SVRA N/A

Revenue Next Year
TMC N/A
SVRA N/A

P/E Ratio
TMC N/A
SVRA N/A

Revenue Growth
TMC N/A
SVRA N/A

52 Week Low
TMC $0.72
SVRA $2.26

52 Week High
TMC $3.80
SVRA $5.31

Technical

Relative Strength Index (RSI)
TMC 57.10
SVRA 56.12

Support Level
TMC $2.81
SVRA $3.12

Resistance Level
TMC $3.30
SVRA $3.56

Average True Range (ATR)
TMC 0.41
SVRA 0.18

MACD
TMC -0.03
SVRA -0.02

Stochastic Oscillator
TMC 51.90
SVRA 55.11

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: